78 related articles for article (PubMed ID: 3690582)
21. Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects.
Lehmann HD; Giertz H; Kretzschmar R; Lenke D; von Philipsborn G; Raschack M; Schuster J
Arzneimittelforschung; 1981; 31(9a):1544-57. PubMed ID: 7197969
[No Abstract] [Full Text] [Related]
22. Intravenous dilazep reduces blood pressure and peripheral vascular resistance in humans.
Poggesi L; Masotti G; Serneri GG; Carnovali M
J Clin Pharmacol; 1988 Jan; 28(1):43-7. PubMed ID: 3280614
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator.
Saito D; Kusachi S; Nagashima H; Haraoka S
Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820
[TBL] [Abstract][Full Text] [Related]
24. [Effect of nicardipine on myocardial contractility and coronary tone in vitro].
Raddino R; Ferrari R; Visioli O
Cardiologia; 1987 Feb; 32(2):193-7. PubMed ID: 3594501
[No Abstract] [Full Text] [Related]
25. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
Lochner W
Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
[No Abstract] [Full Text] [Related]
26. The inhibitory effect of dilazep on in vivo accumulation of platelets onto the damaged aorta in rabbit. II. Morphological analysis.
Sumiyoshi A; Hayashi T
Thromb Res; 1983 Jan; 29(1):37-42. PubMed ID: 6836545
[TBL] [Abstract][Full Text] [Related]
27. [Induction of coronary vascularization by dilazep in experimental animals].
Schmitt G; Winter R; St Müller U; Hauss WH
Arzneimittelforschung; 1972 Apr; 22(4):663-6. PubMed ID: 5068244
[No Abstract] [Full Text] [Related]
28. Comparative effects of dopamine and norepinephrine on myocardial function and metabolism during experimental cardiogenic shock.
Bagwell EE; Daniell HB
J Pharmacol Exp Ther; 1970 Jun; 173(2):357-63. PubMed ID: 5434019
[No Abstract] [Full Text] [Related]
29. Calcium antagonists and vascular smooth muscle.
Flaim SF
Prog Clin Biol Res; 1986; 219():311-52. PubMed ID: 3786324
[No Abstract] [Full Text] [Related]
30. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
31. The inhibition effect of dilazep on in vivo accumulation of platelets onto the damaged aorta in rabbit. I. Quantitative radioisotopic analysis.
Sumiyoshi A; Hayashi T; Fujii M
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):381-6. PubMed ID: 7324003
[No Abstract] [Full Text] [Related]
32. [Pituitary adrenocorticotropic hormone in the regulation of the cardiovascular system].
Bychenko IG
Usp Sovrem Biol; 1980; 89(3):461-72. PubMed ID: 6251657
[No Abstract] [Full Text] [Related]
33. [Effect of cadmium on blood pressure and contractile activity of isolated aortic muscle in rabbits].
Li AH; Hou TD; Cheng F; Zhang J; Tang Y; Wang RQ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Nov; 24(11):666-8. PubMed ID: 17181944
[No Abstract] [Full Text] [Related]
34. [Effects of dilazep on platelet thrombus formation and intimal thickening after mechanical injury of aorta in rabbit].
Hayashi T
Fukuoka Igaku Zasshi; 1988 Oct; 79(10):723-37. PubMed ID: 3248764
[No Abstract] [Full Text] [Related]
35. [Effects of Thalamonal on the coronary circulation and cardiac efficiency].
Yusa T; Iwatsuki K
Masui; 1971 May; 20(5):377-81. PubMed ID: 5103809
[No Abstract] [Full Text] [Related]
36. Effects of capsaicin on mechanoenergetics of excised cross-circulated canine left ventricle and coronary artery.
Takaki M; Akashi T; Ishioka K; Kikuta A; Matsubara H; Yasuhara S; Fujii W; Suga H
J Mol Cell Cardiol; 1994 Sep; 26(9):1227-39. PubMed ID: 7815465
[TBL] [Abstract][Full Text] [Related]
37. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
[TBL] [Abstract][Full Text] [Related]
38. [Effect of inderal on the coronary blood circulation].
Kaverina NV; Kareva GF; Markova GA
Farmakol Toksikol; 1968; 31(2):169-74. PubMed ID: 5674669
[No Abstract] [Full Text] [Related]
39. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
Sano N; Katsuki S; Kawada M
Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
[No Abstract] [Full Text] [Related]
40. [Action of glucagon on cardiac hemodynamics, coronary circulation and myocardial metabolism in humans].
Warembourg H; Houdas Y; Bertrand ME; Ketelers JY; Vermeersch M
Arch Mal Coeur Vaiss; 1969 Aug; 62(8):1080-95. PubMed ID: 4983769
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
